Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease-Reference-Cited by-同舟云学术

Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease

Published:2023-04 Issue:4 Volume:103 Page:791-797
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Naylor Kyla L.,McArthur Eric,Dixon Stephanie N.,Kwong Jeffrey C.,Thomas Doneal,Balamchi Shabnam,Blake Peter G.,Garg Amit X.,Atiquzzaman Mohammad^ORCID,Hladunewich Michelle A.,Levin Adeera,Yeung Angie,Oliver Matthew J.

Publisher

Elsevier BV

Subject

Nephrology

Reference7 articles.

1. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study;Chung;BMJ,2021

2. A call for caution in use of pertussis vaccine effectiveness studies to estimate waning immunity: a Canadian Immunization Research Network study;Crowcroft;Clin Infect Dis,2021

3. Province-wide prevalence testing for SARS-CoV-2 of in-center hemodialysis patients and staff in Ontario, Canada: a cross-sectional study;Sniekers;Can J Kidney Heal Dis,2021

4. The prevalence of symptoms in end-stage renal disease: a systematic review;Murtagh;Adv Chronic Kidney Dis,2007

5. Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies;Ioannidis;BMJ Evidence-Based Med,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Vaccine Effectiveness Among Patients With Maintenance Dialysis; Observations From Population Level Cohort Studies in 2 Large Canadian Provinces;Canadian Journal of Kidney Health and Disease;2023-01